First Header Logo Second Header Logo

Impact of Minimally Invasive Benign Prostatic Hyperplasia Therapies on 30- and 90-Day Postoperative Office Encounters.

Pathak RA, Broderick GA, Igel TC, Petrou SP, Young PR, Wehle MJ, Heckman MG, Diehl NN, Vargas ER, Shah K, Thiel DD. Impact of Minimally Invasive Benign Prostatic Hyperplasia Therapies on 30- and 90-Day Postoperative Office Encounters. Urology. 2017 Jan; 99:186-191.

View in: PubMed